IRB Protocol #: 1704018134

ClinicalTrials.gov Identifier: NCT02290028

Overview: The purpose of this study is to confirm the long-term safety of the BIOTRONIK Sentus QP lead used with the BIOTRONIK CRT-D device. These leads are legally marketed in the United States and not investigational products. The study involves collection and review of data at regular follow-up visits with your doctor.

This trial is funded by BIOTRONIK.

To be eligible, patients must:

• Be a candidate for CRT-D
• Be able and willing to complete all routine study visits at our site through five years of follow up
• Accept Home Monitoring® concept

Patients cannot participate if they have:

• A left ventricular lead already implanted or had prior attempt to place a left ventricular lead
• A cardiac surgical procedure, such as coronary artery bypass graft or valve surgery that is planned to occur within 6 months after implant or ablation that is planned to occur within 90 days after implant
• Another life-threatening, underlying illness separate from their cardiac disorder 

QP ExCELs: Sentus QP – Extended CRT Evaluation with Quadripolar Left Ventricular